查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1146382

快速动物检测市场 - COVID-19 的增长、趋势、影响和预测 (2022-2027)

Veterinary Rapid Test Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，快速动物试验市场预计将以 8.7% 的复合年增长率增长。

在 COVID-19 大流行期间，出现了一些 SARS-CoV-2 感染病例，尤其是在与 COVID-19 感染者直接接触的动物中。儘管 COVID-19 大流行对全球市场产生了负面影响，但随着人们更加关注动物诊断工具的开发以识别动物疾病，快速动物试验取得了积极增长。包括美国在内的多个国家/地区都报告了狗和猫感染 COVID-19 的病例。例如，美国农业部 (USDA) 国家兽医服务实验室 (NVSL) 于 2020 年 6 月发布的一份报告在纽约州的狗（德国牧羊犬）中发现 SARS-CoV-2 (COVID-19 病毒) 被确认为第一次。美国第一隻 SARS-CoV-2 检测呈阳性的狗。同样，根据美国农业部 (USDA) 和美国疾病控制与预防中心 (CDC) 国家兽医服务实验室 (NVSL) 在 2020 年 4 月的报告，两隻宠物猫报告了 SARS-CoV-2 (COVID-19)。19病原病毒）确诊感染病例。这些猫在主人的 COVID-19 检测呈阳性后感染了病毒。例如，2021 年 11 月，路易斯安那州动物疾病诊断实验室 (LADDL) 与路易斯安那州公共卫生部和疾病控制中心 (CDC) 合作，在 2021 年 12 月 31 日之前为路易斯安那州的狗和猫提供 COVID-19。我们已经开始了一个提供免费测试的项目。大流行期间宠物拥有量的增加也促进了市场增长。例如，根据 2021 年 6 月发布的患病动物人民医院 (PDSA) PAW 报告，2020 年 3 月至 2021 年 5 月期间，英国有 200 万人养了宠物。这一趋势对 COVID-19 大流行期间的市场增长产生了积极影响。

消费者对科学动物营养意识的提高、工业化牲畜生产的增加以及对动物性蛋白质来源需求的增加是促进所研究市场增长的因素。肉类、牛奶和鸡蛋是最近需求激增的食品之一。由于资源枯竭和耕地不足导致农业生产力下降，动物源性食品的消费量正在增加。动物源性食品是蛋白质的重要来源，富含蛋白质的饮食对于保持身体健康很重要。根据粮食及农业组织统计数据库，2020年动物蛋白消费量在富裕国家稳定（44-55克/人/天），而在发展中国家消费量在增加。我知道。例如，根据 2022 年 8 月发布的美国农业部对外农业服务局的数据，到 2020 年，美国将占全球牛肉消费量的约 21%。 2020 年，亚洲消费了 19,656,460 吨牛肉和小牛肉，预计到 2026 年将增加到 21,467,080 吨。预计农民将增加畜产品的产量，以满足对动物性饮食日益增长的需求。牲畜疾病是造成牲畜系统中一系列问题的原因，包括生产力下降、粮食安全不安全和收入损失，并且还对人类健康产生不利影响。因此，牲畜疾病诊断测试的增加已成为推动市场增长的主要因素。

因此，上述因素共同归因于所研究的市场在预测期内的增长。然而，预计新兴国家兽医诊断基础设施不足将阻碍预测期内的市场增长。

主要市场趋势

预计在预测期内快速检测试剂盒将强劲增长

快速检测试剂盒是经济实惠的检测试剂盒，易于在现场或实验室使用，无需显微镜或电力。快速检测试剂盒占了最大的份额，它可以灵活地运行一项或多项测试，允许根据需要进行测试，做出正确的临床决策，节省时间和金钱我认为是因为你可以。快速检测试剂盒很方便，因为它们可以在室温下长期保存并提供快速结果，而且这些快速检测的特异性在 90% 到 100% 之间。另一方面，灵敏度为85%至90%。像这样的准确测试将导致早期诊断和早期治疗，从而增加该领域的需求。

根据2020年6月出版的《不丹诊断狂犬病金标准荧光抗体检测快速免疫层析检测试剂盒评价杂誌》，快速检测试剂盒可用于疑似狂犬病病例的快速反应。据称，在不丹等资源匮乏的国家，该疫苗已显着提高了能力并减少了狂犬病在动物和人类中的进一步传播。由于不丹寻求消除犬传人类狂犬病，因此需要改进敏感性监测以快速识别和根除动物种群中的狂犬病病毒传播。如此快速的诊断结果将增加对快速测试的需求并推动该领域的增长。

北美有望主导快速动物试验市场

由于大量牲畜和人畜共患病以及宠物拥有率高，预计北美将主导市场。在 2020 年 COVID-19 大流行之后，美国和该地区的其他国家采取了非常大的措施来应对大流行病，以改善人类的医疗保健。预防性诊断工具的开发也有助于增加兽医就诊和预防保健。 2021 年 4 月，Mars Veterinary Health 旗下公司 Intech Diagnostics 公布了对 730,000 次兽医诊所就诊的回顾性审查的新数据，显示所有猫的 RenalTech 改进预防保健检测呈阳性或阴性。 Renaltec 预测猫慢性肾病 (CKD) 发病前 2 年。数据显示，预测性诊断工具使兽医诊所的就诊次数增加了 31%。新兴国家对预测诊断工具的研发也在推动该国市场的增长。

与销售额下降形成鲜明对比的是，洛杉矶防止虐待动物协会报告称，2020 年 6 月，宠物动物的收养率翻了一番。据报导，每天大约有10到13隻宠物被领养。根据美国宠物用品协会 (APPA) 全国宠物主人调查 (2021-2022)，美国 70% 的家庭是宠物主人。北美宠物健康保险协会 (NAPHIA) 2021 年行业状况报告显示，2020 年受保宠物总数达到 310 万，高于 2019 年的 250 万。我来了。该报告还指出，狗仍然是主要的受保宠物，占 82.9%，猫占 17.1%。从长远来看，宠物的日益流行和主人对健康的关注可能会推动快速动物试验的发展。

因此，由于上述因素，北美地区的研究市场有望增长。

竞争格局

快速动物试验市场在本质上是分散的，多家公司在全球和区域开展业务。竞争格局占据市场份额，着名的 Zoetis, Inc、IDEXX Laboratories, Inc、Heska Corporation、Thermo Fisher Scientific Inc、Biopanda Reagents Ltd、Fassisi GmbH、Virbac、BioNote, Inc、SWISSAVANS AG、MEGACOR Diagnostik 包括分析多家国际和本地公司，例如 GmbH、Woodley Equipment Company。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 人畜共患疾病的流行和发病率上升
    • 对动物源性食品的需求增加
    • 伴侣动物数量增加
  • 市场製约因素
    • 新兴国家的兽医诊断基础设施不足
    • 飙升的宠物护理费用
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品分类
    • 快速测试套件
    • 快速测试阅读器
  • 通过申请
    • 病毒性疾病
    • 细菌性疾病
    • 寄生虫病
    • 过敏症
    • 其他用途
  • 按动物类型
    • 伴侣动物
    • 家畜
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Zoetis, Inc.
    • IDEXX Laboratories, Inc.
    • Heska Corporation
    • Thermo Fisher Scientific Inc.
    • Biopanda Reagents Ltd.
    • Fassisi GmbH
    • Virbac
    • BioNote, Inc.
    • MEGACOR Diagnostik GmbH
    • Woodley Equipment Company

第七章市场机会与未来趋势

简介目录
Product Code: 92040

The veterinary rapid test market is expected to register a CAGR of 8.7% over the forecast period.

There were a few cases of SARS-CoV-2 infection in animals during the COVID-19 pandemic, especially in animals that had direct contact with COVID-19-infected people. More attention is being paid to the development of veterinary diagnostics tools for identifying diseases in animals which led to a positive growth in veterinary rapid tests despite the COVID-19 pandemic's ongoing negative effects on worldwide markets. There have been cases of COVID-19 infections in cats and dogs in a several countries, including the United States. For instance, according to a report National Veterinary Services Laboratories (NVSL) of the United States Department of Agriculture (USDA), published on June 2020, the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19) infection in a pet dog (German shepherd) in the state of New York. The first dog to test positive for SARS-CoV-2 in the US. Similarly, according to the National Veterinary Services Laboratories (NVSL) of the United States Department of Agriculture (USDA) and the Centers for Disease Control and Prevention (CDC) in April 2020, announced confirmed cases of SARS-CoV-2 (the virus that causes COVID-19) infection in two pet cats. These cats got infected by the virus after their owner tested positive for COVID-19. For instance, in November 2021, the Louisiana Animal Disease Diagnostic Laboratory (LADDL) partnered with the Louisiana Office of Public Health and the Centers for Disease Control (CDC) on a project to provide free COVID-19 testing for dogs and cats in Louisiana through December 31, 2021. Also, the increasing pet adoption during the pandemic has contributed to the market's growth. For instance, according to the People's Dispensary for Sick Animals (PDSA) PAW report published in June 2021, 2 million people in the United Kingdom acquired pets between March 2020 to May 2021. This trend has positively impacted the market growth during the COVID-19 pandemic.

Increasing consumer awareness regarding scientific animal nutrition, increase in industrialized livestock production, and the increasing demand for animal-based protein sources are the factors augmenting the growth of the market studied. Meat, milk, and eggs are among the foods whose demand has surged recently. Due to declining agricultural productivity as a result of depleting resources and a shortage of cultivated land, the consumption of animal-derived foods is rising. Foods derived from animals are a key source of protein and eating a diet high in protein is crucial for maintaining good health. According to Food and Agriculture Organization Corporate Statistical Database, in 2020, animal protein consumption in wealthy nations is steady (between 44 and 55 g / capita / day), whereas consumption is rising in developing nations. For instance, according to USDA Foreign Agricultural Service, published in August 2022, the U.S. accounted for about 21% of the world's beef consumption in 2020. Asia consumed 19,656.46 thousand tons of beef and veal in 2020, and that number is projected to rise to 21,467.08 thousand tons by 2026. In order to meet the rising demand for meals derived from animals, farmers are anticipated to boost livestock production. Livestock diseases are contributing to a set of problems within the livestock production systems, including productivity losses, uncertain food security, and loss of income, adversely affecting human health. Thus, increasing diagnostic testing of livestock diseases are the major factors driving the growth of the market.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However inadequate veterinary diagnostics infrastructure in developing countries are expected to hinder the market growth over the forecast period.

Key Market Trends

Rapid Test Kits is Expected to Witness High Growth Over the Forecast Period

Rapid Test Kits is affordable, speedy, and easy to use in the field or laboratory setting without the need for a microscope or electricity, and it quick (5-10 minutes) results. Rapid Test Kits are found to hold the largest share which can be attributed to the flexibility to perform single or multiple tests so that the test is performed as needed to make the right clinical decisions and avoid wasted time and money. Rapid test kits are convenient to store at room temperature for an extended period of time where the results are obtained faster and the specificity of these rapid tests ranges from 90% to 100%. In comparison, sensitivity ranges from 85% to 90% in a given rapid test kit. Such accurate testing will lead to an early diagnosis and treatment which will boost the segment demand.

According to a "Journal on Evaluation of a rapid immunochromatographic test kit to the gold standard fluorescent antibody test for diagnosis of rabies in animals in Bhutan", published in June 2020, the rapid kits have significantly improved the ability to deliver a rapid response to suspected rabies cases and decreased further rabies spread in both animals and people in resource-constrained nations like Bhutan. To quickly identify and eradicate rabies virus circulation in animal populations, sensitivity surveillance must be improved as Bhutan is on the verge of eliminating dog-mediated human rabies. Such rapid diagnostic result will increase the demand of rapid test boosting the segment growth.

North America is Expected to Dominate the Veterinary Rapid Test Market

North America is expected to dominate the market owing to factors such as high prevalence of livestock animals and zoonotic diseases coupled with the rising pet ownership in the region. After the 2020 COVID-19 pandemic, the United States and other states in the region have taken extraordinary steps to cope with the pandemic situation for improved human healthcare was tremendous. The development of preventive diagnostic tools also contributes to the increasing veterinary visits and preventive care. In April 2021, Intech Diagnostics, a part of Mars Veterinary Health, released new data that shows that all cats from a retrospective review of 730,000 veterinary visits received improved preventive care following a positive or negative RenalTech. RenalTech predicts chronic kidney disease (CKD) in cats two years before it occurs. The data shows that the predictive diagnostic tool increased veterinary visits by as much as 31%. Such studies and the development of predictive diagnostics tools are also driving the market growth in the country.

In contrast to the decline in sales, as per the reports of the Society for the Prevention of Cruelty to Animals, Los Angeles, the rate of adoption of pet animals was doubled in June 2020. The report suggests daily adoptions of pet animals were about 10 to 13 per day. According to American Pet Products Association's (APPA) National Pet Owners Survey (2021-2022) 70% of households in the United States reported as pet owners. North American Pet Health Insurance Association (NAPHIA), State of the Industry Report for 2021 show the total number of pets insured in 2020 reached 3.1 million, up from 2.5 million in 2019. This report also states that dogs continue to be the major insured pets with 82.9% and cats for 17.1%. The rising adoption of pets and their health concern by the owner may drive the growth of veterinary rapid test in the longer term.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Competitive Landscape

The veterinary rapid test market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known include Zoetis, Inc., IDEXX Laboratories, Inc., Heska Corporation, Thermo Fisher Scientific Inc., Biopanda Reagents Ltd., Fassisi GmbH, Virbac, BioNote, Inc., SWISSAVANS AG, MEGACOR Diagnostik GmbH, and Woodley Equipment Company, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence and Incidence of Zoonotic Diseases
    • 4.2.2 Increasing Demand for Animal-Derived Food Products
    • 4.2.3 Growth in Companion Animal Population
  • 4.3 Market Restraints
    • 4.3.1 Inadequate Veterinary Diagnostics Infrastructure in Developing Countries
    • 4.3.2 High in Pet Care Cost
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Rapid Test Kits
    • 5.1.2 Rapid Test Readers
  • 5.2 By Application
    • 5.2.1 Viral Diseases
    • 5.2.2 Bacterial Diseases
    • 5.2.3 Parasitic Diseases
    • 5.2.4 Allergies
    • 5.2.5 Other Applications
  • 5.3 By Animal Type
    • 5.3.1 Companion Animals
    • 5.3.2 Livestock Animals
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Zoetis, Inc.
    • 6.1.2 IDEXX Laboratories, Inc.
    • 6.1.3 Heska Corporation
    • 6.1.4 Thermo Fisher Scientific Inc.
    • 6.1.5 Biopanda Reagents Ltd.
    • 6.1.6 Fassisi GmbH
    • 6.1.7 Virbac
    • 6.1.8 BioNote, Inc.
    • 6.1.9 MEGACOR Diagnostik GmbH
    • 6.1.10 Woodley Equipment Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS